FDA Center for Drug Evaluation & Research Issues Warning Letter to Ong Tien USA
November 04, 2026
November 04, 2026
WASHINGTON, Nov. 4 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Ong Tien USA LLC from its Center for Drug Evaluation and Research:
* * *
Recipient: Ong Tien USA LLC, 11209 Bellaire Blvd, Houston, TX 77072-2536, United States, ongtienlinhchi@gmail.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
Refer . . .
* * *
Recipient: Ong Tien USA LLC, 11209 Bellaire Blvd, Houston, TX 77072-2536, United States, ongtienlinhchi@gmail.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
Refer . . .
